Condition
Gastric Intestinal Metaplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Gastric Intestinal Metaplasia clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Latvia (1)). By phase: Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Gastric Intestinal Metaplasia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AI-assisted scoring for gastric IM using EGGIM shows how well doctors trained | — | Jinan, Shandong | Recruiting | Oct 6, 2025 |
| Ursodeoxycholic acid for reversing gastric intestinal metaplasia | Phase 4 | Pingdingshan, Henan and 5 other locations | Recruiting | Sep 24, 2024 |
| Weifuchun tablets versus folic acid to reverse gastric intestinal metaplasia | Phase 4 | Ankang and 8 other locations | Recruiting | Sep 24, 2024 |
| Reversing stomach intestinal metaplasia using pyrvinium | Phase 2 | Durham, North Carolina | Recruiting | Sep 19, 2024 |
| Collecting health information to understand and prevent gastric cancer | — | Basking Ridge, New Jersey and 6 other locations | Recruiting | Apr 17, 2024 |
| Monitoring patients with precancerous stomach lesions | — | Riga | Recruiting | Aug 15, 2017 |
All recruiting trials (6)
-
AI-assisted scoring for gastric IM using EGGIM shows how well doctors trained
This trial tests whether AI-assisted EGGIM scoring helps endoscopists better identify gastric intestinal metaplasia in patients.
-
Ursodeoxycholic acid for reversing gastric intestinal metaplasia
This study will test whether taking ursodeoxycholic acid for six months can reverse gastric intestinal metaplasia in adults who do not have Helicobacter pylori infection.
-
Weifuchun tablets versus folic acid to reverse gastric intestinal metaplasia
This trial tries to see if taking Weifuchun tablets daily for six months can reverse gastric intestinal metaplasia in adults without Helicobacter pylori compared with daily folic acid.
-
Reversing stomach intestinal metaplasia using pyrvinium
This trial will test whether a two-week course of the drug pyrvinium can reduce or reverse high-risk gastric intestinal metaplasia in adults at increased risk for stomach cancer.
-
Collecting health information to understand and prevent gastric cancer
This study is trying to gather health information from people with early signs of gastric cancer, as well as healthy individuals and those already diagnosed, to better understand what might lead to this type of cancer.
-
Monitoring patients with precancerous stomach lesions
This study is trying to find out how to better monitor people with precancerous stomach lesions to see who is at risk of developing gastric cancer and when they should come back for check-ups.
Related topics
Quick answers
How many Gastric Intestinal Metaplasia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Latvia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.